Skip to main content

Sucralfate

FDA recalls

2 rows

DateCompany and reasonClass
Oct 17, 2023Vistapharm LLC
Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
Class I · Terminated
Aug 29, 2023Vistapharm LLC
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Class II · Terminated

← Back to Sucralfate

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).